<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000613209"><TermName>fludarabine phosphate</TermName><TermPronunciation>(floo-DAR-uh-been FOS-fayt)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat B-cell chronic lymphocytic leukemia (CLL) that has not responded to treatment with other anticancer drugs or that has gotten worse. It is also being studied in the treatment of other types of cancer. Fludarabine phosphate blocks cells from making DNA and may kill cancer cells. It is a type of purine antagonist and a type of ribonucleotide reductase inhibitor. Also called Fludara.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720867" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fludarabine phosphate&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720866" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;fosfato de fludarabina&quot;" language="es" id="_4"/><SpanishTermName>fosfato de fludarabina</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la leucemia linfocítica crónica (LLC) de células B que no ha respondido al tratamiento con otros medicamentos contra el cáncer o que ha empeorado. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. El fosfato de fludarabina impide que las células produzcan ADN y puede destruir las células cancerosas. Es un tipo de antagonista de la purina y un tipo de inhibidor de la ribonucleótido reductasa. También se llama Fludara.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-08-25</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000597019">Fludarabine Phosphate</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
